CheckMyRecalls

Granules Pharmaceuticals Inc. recalls Metoprolol Succinate…

Granules Pharmaceuticals Inc. recalls Metoprolol Succinate Extended-Release Tablets

Published
9 Jul 2025
Units affected
27,648 100-count Bottles; 5,376 500-count Bottles
Agency
FDA
Country
United States

The hazard

Failed Dissolution Specifications: Product failed to meet dissolution acceptance criteria in the stability studies at the 6th month (25¿C/60% RH) long-term.

Classification: Class II — this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What to do

Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.

  • Check the lot number on the box or bottle.
  • Talk to your pharmacist or doctor before stopping any prescribed medicine.
  • Return the product to the pharmacy for safe disposal.
Read the official FDA notice

Product details

Metoprolol Succinate Extended-Release Tablets, USP, 25 mg, Packaged in a) 100-count bottle, NDC 70010-780-01; b) 500-count bottle, NDC 70010-780-05; Rx only, Manufactured by: Granules India Limited, Hyderadab-500 081, India, Manufactured for: Granules Pharmaceuticals Inc., Chantilly, VA 20151,

Brand / company
Granules Pharmaceuticals Inc.
Codes / lots
Lot # a)1400008A, Exp Date: 12/31/2025; b) 1400008B, Exp Date: 12/31/2025
Distribution
Nationwide in the USA.
Recall status
Ongoing

Source: U.S. Food and Drug Administration, published 9 Jul 2025. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.